{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T23:20:39Z","timestamp":1769642439087,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.bmc.2022.116722","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:43:00Z","timestamp":1648064580000},"page":"116722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Broad-spectrum cyclic boronate \u03b2-lactamase inhibitors featuring an intramolecular prodrug for oral bioavailability"],"prefix":"10.1016","volume":"62","author":[{"given":"K.","family":"Raja Reddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxim","family":"Totrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Lomovskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad","family":"Tarazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew C.","family":"Clifton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9082-1982","authenticated-orcid":false,"given":"Scott J.","family":"Hecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bmc.2022.116722_b0005","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1023\/A:1012272403776","article-title":"The development of \u03b2-lactam antibiotics in response to the evolution of \u03b2-lactamases","volume":"18","author":"Essack","year":"2001","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.bmc.2022.116722_b0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0020-2452(98)80009-2","article-title":"\u03b2-Lactam antibiotics, \u03b2-lactamases and bacterial resistance","volume":"96","author":"Kotra","year":"1998","journal-title":"Bull Inst Pasteur (Paris)"},{"issue":"1","key":"10.1016\/j.bmc.2022.116722_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/45.1.1","article-title":"Carbapenems: the pinnacle of the \u03b2-lactam antibiotics or room for improvement?","volume":"45","author":"Edwards","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.bmc.2022.116722_b0020","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/CMR.00001-07","article-title":"Carbapenemases: the versatile \u03b2-lactamases","volume":"20","author":"Queenan","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"17","key":"10.1016\/j.bmc.2022.116722_b0025","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1080\/14656566.2019.1660772","article-title":"The latest advances in \u03b2-lactam\/\u03b2-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections","volume":"20","author":"Papp-Wallace","year":"2019","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.bmc.2022.116722_b0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41579-019-0159-8","article-title":"Interplay between \u03b2-lactamases and new \u03b2-lactamase inhibitors","volume":"17","author":"Bush","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2022.116722_b0035","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1021\/acs.jmedchem.9b01976","article-title":"Discovery of cyclic boronic acid QPX7728, an ultra-broad-spectrum inhibitor of serine and Metallo \u03b2 -lactamases","volume":"63","author":"Hecker","year":"2020","journal-title":"J. Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2022.116722_b0040","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1021\/acs.jmedchem.5b00127","article-title":"Discovery of a cyclic boronic acid \u03b2-lactamase inhibitor (RPX7009) with utility vs class A serine carbapenemases","volume":"58","author":"Hecker","year":"2015","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2022.116722_b0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/1521-3773(20020104)41:1<152::AID-ANIE152>3.0.CO;2-N","article-title":"A boronic ester annulation strategy for diversity-oriented organic synthesis","volume":"41","author":"Micalizio","year":"2002","journal-title":"Angew Chem Int Ed"},{"issue":"20","key":"10.1016\/j.bmc.2022.116722_b0050","doi-asserted-by":"crossref","first-page":"10009","DOI":"10.1021\/jo4013942","article-title":"Boronic esters in asymmetric synthesis","volume":"78","author":"Matteson","year":"2013","journal-title":"J Org Chem"},{"issue":"12","key":"10.1016\/j.bmc.2022.116722_b0055","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1021\/jm100244y","article-title":"Synthesis and biological characterization of the histone deacetylase inhibitor largazole and C7-modified analogues","volume":"53","author":"Souto","year":"2010","journal-title":"J Med Chem"},{"issue":"14","key":"10.1016\/j.bmc.2022.116722_b0060","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1021\/ja068455x","article-title":"Total synthesis of plusbacin A3: a depsipeptide antibiotic active against vancomycin-resistant bacteria","volume":"129","author":"Wohlrab","year":"2007","journal-title":"J Am Chem Soc"},{"issue":"10","key":"10.1016\/j.bmc.2022.116722_b0065","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0040-4020(01)86300-6","article-title":"Asymmetric hydrogenation of 3,5-dioxo esters catalyzed by Ru-binap complex: a short step asymmetric synthesis of 6-substituted 5,6-dihydro-2-pyrones","volume":"49","author":"Shao","year":"1993","journal-title":"Tetrahedron"},{"issue":"1","key":"10.1016\/j.bmc.2022.116722_b0070","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1021\/om950574q","article-title":"(Alkoxyalkyl)boronic ester intermediates for asymmetric synthesis","volume":"15","author":"Matteson","year":"1996","journal-title":"Organometallics"},{"issue":"13","key":"10.1016\/j.bmc.2022.116722_b0075","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.jorganchem.2008.03.031","article-title":"Synthesis of a (\u03b2-acetamido-\u03b1-acetoxyethyl)boronic ester via azido boronic esters","volume":"693","author":"Matteson","year":"2008","journal-title":"J Organomet Chem"},{"issue":"15","key":"10.1016\/j.bmc.2022.116722_b0080","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.1021\/jo990245y","article-title":"First stereocontrolled synthesis of the (3S,5R,7R,10R,11R)-C1-C13 fragment of nystatin A1","volume":"64","author":"Solladie","year":"1999","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2022.116722_b0085","unstructured":"Hecker SJ, Reddy KR, Totrov M, et al. Discovery of RPX7009, a broad-spectrum beta-lactamase inhibitor with utility vs. class A serine carbapenemases. In: Abstracts of Papers, 52nd International Conference on Antimicrobial Agents and Chemotherapy, #F-848, San Francisco, CA, 2012."},{"issue":"13","key":"10.1016\/j.bmc.2022.116722_b0090","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1021\/ol026040k","article-title":"Synthesis of the core structure of salicylihalamide a by intramolecular Suzuki reaction","volume":"4","author":"Bauer","year":"2002","journal-title":"Org Lett"},{"issue":"10","key":"10.1016\/j.bmc.2022.116722_b0095","doi-asserted-by":"crossref","first-page":"9344","DOI":"10.1074\/jbc.M312356200","article-title":"Hydrolysis of third-generation cephalosporins by class C beta-lactamases. Structures of a transition state analog of cefotoxamine in wild-type and extended spectrum enzymes","volume":"279","author":"Nukaga","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2022.116722_b0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1097-0134(1997)1+<215::AID-PROT29>3.0.CO;2-Q","article-title":"Flexible protein-ligand docking by global energy optimization in internal coordinates","volume":"Suppl 1","author":"Totrov","year":"1997","journal-title":"Proteins"},{"key":"10.1016\/j.bmc.2022.116722_b0105","unstructured":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - ninth edition. Clinical and Laboratory Standards Institute, M07-A9 32(2) (2012) 1-68."}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622001146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622001146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:17:23Z","timestamp":1760836643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622001146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":21,"alternative-id":["S0968089622001146"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116722","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Broad-spectrum cyclic boronate \u03b2-lactamase inhibitors featuring an intramolecular prodrug for oral bioavailability","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116722"}}